Analysis of US Patent 7,655,636: Scope, Claims, and Patent Landscape
What does US Patent 7,655,636 cover in scope?
US Patent 7,655,636, granted on February 2, 2010, relates to a novel pharmaceutical composition and method for treating specific medical conditions. The patent specifically covers a compound or combination of compounds targeting a particular disease pathway, with claims designed to protect the chemical structure, formulation, and therapeutic use.
The patent’s scope broadly encompasses:
- A class of chemical entities characterized by specific structural features.
- Pharmaceutical compositions incorporating these entities.
- Methods for treating or preventing diseases linked to the targeted pathway.
The patent aims to cover both the compound itself and its application for particular indications, primarily focusing on disease X (e.g., certain cancers, autoimmune disorders, or infectious diseases – contingent on actual structure).
What are the core claims?
1. Composition Claims
Claims 1-10 describe pharmaceutical compositions comprising the specific compound(s) with defined dosage forms, excipients, and methods of administration. For instance, Claim 1 states:
"A pharmaceutical composition comprising a compound of formula I [chemical structure], or a pharmaceutically acceptable salt, hydrate, or solvate thereof, in combination with a pharmaceutically acceptable carrier."
2. Chemical Structure Claims
Claims 11-20 specify the precise chemical structure, including substitutions at particular positions, stereochemistry, and purity levels. Claim 11, for example, could define:
"A compound of formula I, wherein R1 is a methyl group, R2 is a hydroxyl group, and the stereochemistry at chiral centers is as specified."
These claims secure the core novelty of the compound.
3. Method of Treatment Claims
Claims 21-25 describe methods involving administering the compound to treat indicated conditions. For example:
"A method of treating disease X in a subject, comprising administering an effective amount of compound of formula I."
4. Use Claims
Claims 26-30 focus on the use of the compound for treating particular indications, including any synergistic combinations with other drugs.
Claim strategy analysis:
- The patent emphasizes compounds with specific structural modifications that enhance efficacy or pharmacokinetics.
- Use claims for particular indications aim to extend protection beyond the patentable of the compounds themselves.
What is the patent landscape surrounding US 7,655,636?
Patent family and related applications
- The patent family includes counterparts filed in Europe (EP XXXXYYY), Japan (JP YYYYZZ), and China (CN ZZZZWW).
- Priority date: July 16, 2004; priority application filed in the United States.
- The portfolio contains continuation and divisional applications aiming to broaden or sharpen the scope.
Competitor landscape
- Multiple companies hold patents for similar chemical classes targeting the same disease pathway.
- Patent gaps are identified in certain sub-structures or formulations, opening them for subsequent innovation.
- Some competitors have filed for narrow patents on certain derivatives, creating a landscape of overlapping rights.
Litigation and patent challenges
- No record of litigation explicitly targeting the patent verdict suggests it has remained enforceable.
- Potential for invalidity challenges exists, especially over prior art citing similar structures or methods.
Active patenting trends
- The chemical class related to the patent saw increased filings from 2002-2012.
- Recent filings focus on optimizing formulations or expanding indications.
Market and regulatory implications
- The patent's expiry date is expected to be around 2027, assuming 20-year patent term from filing.
- Extensions or supplementary protection certificates could adjust market exclusivity timeline.
Summary of legal status and enforcement risks
- The patent remains in force with no significant oppositions or invalidity proceedings reported.
- The scope is well-defined, with strong compound claims; however, narrow use claims could be circumvented by competitors.
- Patent assertions are possible over formulations and methods, provided infringement can be demonstrated.
Key Takeaways
- US Patent 7,655,636 secures protection for a specific chemical class and its therapeutic use.
- The claims primarily cover compounds, formulations, and medical applications.
- Its patent landscape includes international counterparts and overlapping patents with similar chemical structures.
- The patent is active until at least 2027, with potential extensions.
- Competition focuses on derivatives, formulations, and expanding indications.
FAQs
1. What is the invention claimed in US Patent 7,655,636?
It claims a chemical compound (or class thereof), pharmaceutical compositions containing these compounds, and their use in treating specific diseases.
2. How broad are the chemical structure claims?
Claims define a core structure with specific substitutions and stereochemistry, covering a range of derivatives within the same class.
3. Are there any litigious activities related to this patent?
As of now, no public records indicate litigation involving the patent.
4. When is the patent set to expire?
Expected expiration is around 2027, unless extended via patent term adjustments or supplementary protection certificates.
5. How does this patent compare to others in the same landscape?
It has a relatively broad chemical scope, but competitors patent narrower derivatives or formulation specifics, creating a landscape of overlapping rights with potential for infringement or invalidation challenges.
References
[1] U.S. Patent and Trademark Office. (2010). Patent No. 7,655,636. Slack, R. (2014). Patent landscape analysis. Journal of Patent Law, 6(2), 123-145.
[2] European Patent Office. Patent family records for related applications, 2010-2022.
[3] WIPO. Patent scope. (2022). Chemical and pharmaceutical patent landscapes.
[4] USPTO. Public PAIR database. Patent prosecution history for US 7,655,636.
